Search for dissertations about: "cardiovascular manifestations in SLE"
Showing result 1 - 5 of 14 swedish dissertations containing the words cardiovascular manifestations in SLE.
-
1. Studies on hereditary C2 deficiency: Frequent occurrence of severe infections, atherosclerosis and rheumatological manifestations
Abstract : The complement system is a part of the innate immunity and is essential in the defence against microorganisms. Hereditary C2 deficiency (C2D) is one of the most common complement deficiency states with an estimated prevalence of 1:20,000 in persons of Western descent. READ MORE
-
2. Systemic Lupus Erythematosus, with focus on vascular wall changes, cardiac risk-factor awareness and cardiovascular events
Abstract : Systemic Lupus Erythematosus is an autoimmune disease with a wide range of disease manifestations with respect to severity and magnitude of organ involvement. An increased risk of cardiovascular disease (CVD) compared with the general population causes both morbidity and mortality in SLE patients. READ MORE
-
3. Cardiovascular disease in systemic lupus erythematosus
Abstract : Premature cardiovascular disease (CVD) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). This is an important clinical problem and a main objective of this study was to identify risk factors and underlying mechanisms. READ MORE
-
4. Autoimmunity in Africa: Comparing Systemic Lupus Erythematosus and Anti-phospholipid Antibodies in Sudan and Sweden
Abstract : Systemic Lupus Erythematosus (SLE) is a chronic immune complex (IC)-mediated disease with variable prevalence worldwide, reported to be more common in Africans, Hispanics and Asians than in Caucasian populations. Expression of autoantibodies might vary between different ethnic populations due to environmental and genetic factors. READ MORE
-
5. Lipids and autoimmunity in atherosclerosis and cardiovascular diseases
Abstract : Atherosclerosis is an inflammatory disease. The rupture of athrerosclerotic plaques is the major cause of severe cardiovascular disease (CVD), such as myocardial infarction (MI) and stroke. The stability of the plaque depends on its cellular and extracellular contents. READ MORE